Other OTC Pharmaceuticals - North America

North America

Highlights

In 2024, the revenue in the Other OTC Pharmaceuticals market in North America amounts to US$7.73bn.
It is projected to experience an annual growth rate of 0.95% (CAGR 2024-2029).
When compared globally, the United States generates the highest revenue, reaching US$7.17bn in 2024.
Taking into account the total population figures, per person revenues of US$15.14 are generated in 2024.
North America's Other OTC Pharmaceuticals market is experiencing a surge in demand for natural and herbal remedies.

Key regions:

Market definitionIn-Scope/Out-of-scopeMarket structureReportsMethodology

The Other OTC Pharmaceuticals market in North America is experiencing steady growth due to various factors such as customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors.Customer preferences in North America play a significant role in the development of the Other OTC Pharmaceuticals market. Consumers in this region are increasingly seeking self-care options and are more inclined towards over-the-counter products for minor ailments. The convenience of purchasing these products without a prescription and the perception of them being safe and effective contribute to the growing demand.Trends in the market also contribute to the development of the Other OTC Pharmaceuticals market in North America. One notable trend is the increasing popularity of natural and herbal remedies. Consumers are becoming more conscious about the ingredients in the products they use and are opting for natural alternatives. This trend has led to the introduction of a wide range of herbal and natural OTC pharmaceuticals in the market.Another trend driving the market is the rising prevalence of chronic diseases such as diabetes, cardiovascular diseases, and respiratory disorders. As the population ages and the incidence of these diseases increases, there is a greater demand for OTC pharmaceuticals that can help manage symptoms and provide relief. This trend has led to the development of specialized OTC products targeting specific health conditions.Local special circumstances also play a role in the development of the Other OTC Pharmaceuticals market in North America. The region has a well-established healthcare system with easy access to pharmacies and drugstores. This accessibility, coupled with the high level of consumer awareness and education, contributes to the growth of the market. Additionally, the presence of large retail chains and online platforms provides consumers with a wide range of options to choose from.Underlying macroeconomic factors also contribute to the growth of the Other OTC Pharmaceuticals market in North America. The region has a stable and growing economy, which allows consumers to spend on healthcare products. Moreover, the increasing healthcare costs and the burden on the healthcare system have led to a shift towards self-care options, including OTC pharmaceuticals.In conclusion, the Other OTC Pharmaceuticals market in North America is developing due to customer preferences for self-care options, trends such as the popularity of natural remedies and the rising prevalence of chronic diseases, local special circumstances including easy access to pharmacies and drugstores, and underlying macroeconomic factors such as a stable economy and increasing healthcare costs.

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.